Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C16H19N3O5 |
| Molecular Weight | 333.3392 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
N[C@H](CCC(=O)N[C@H](CC1=CNC2=C1C=CC=C2)C(O)=O)C(O)=O
InChI
InChIKey=CATMPQFFVNKDEY-DGCLKSJQSA-N
InChI=1S/C16H19N3O5/c17-11(15(21)22)5-6-14(20)19-13(16(23)24)7-9-8-18-12-4-2-1-3-10(9)12/h1-4,8,11,13,18H,5-7,17H2,(H,19,20)(H,21,22)(H,23,24)/t11-,13-/m1/s1
Orilotimod (previously known as Apo 805K1), an antipsoriatic agent that was studied for the treatment of moderate to severe plaque psoriasis. This drug successfully completed phase II clinical trial in the USA. However, information about the further development of this drug is not available.
Originator
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL3137306
Created by
admin on Sat Dec 16 10:08:19 GMT 2023 , Edited by admin on Sat Dec 16 10:08:19 GMT 2023
|
PRIMARY | |||
|
9909
Created by
admin on Sat Dec 16 10:08:19 GMT 2023 , Edited by admin on Sat Dec 16 10:08:19 GMT 2023
|
PRIMARY | |||
|
300000034329
Created by
admin on Sat Dec 16 10:08:19 GMT 2023 , Edited by admin on Sat Dec 16 10:08:19 GMT 2023
|
PRIMARY | |||
|
186087-26-3
Created by
admin on Sat Dec 16 10:08:19 GMT 2023 , Edited by admin on Sat Dec 16 10:08:19 GMT 2023
|
PRIMARY | |||
|
Q66Z43C5XM
Created by
admin on Sat Dec 16 10:08:19 GMT 2023 , Edited by admin on Sat Dec 16 10:08:19 GMT 2023
|
PRIMARY | |||
|
AB-03
Created by
admin on Sat Dec 16 10:08:19 GMT 2023 , Edited by admin on Sat Dec 16 10:08:19 GMT 2023
|
PRIMARY | |||
|
7275810
Created by
admin on Sat Dec 16 10:08:19 GMT 2023 , Edited by admin on Sat Dec 16 10:08:19 GMT 2023
|
PRIMARY | |||
|
C174870
Created by
admin on Sat Dec 16 10:08:19 GMT 2023 , Edited by admin on Sat Dec 16 10:08:19 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
